Rheumatology
| Rheumatoid Arthritis
Rheumatology
Rheumatoid Arthritis

Is the Rheumatoid Arthritis Impact of Disease (RAID) score a meaningful instrument for other inflammatory rheumatic diseases? A cross-sectional analysis of data from the German National Database

book_2 Source: RMD Open. 2022;8(2):e002342.
calendar_today Published on Medfyle: October 2022
import_contacts 7 min
headphones 4 min

In this medfyle

The RAID has been shown to be reliable in the clinical setting as a measure of patient-reported outcomes. This analysis suggests RAID can be used to measure the disease impact on quality of life for a wide spectrum of inflammatory rheumatic diseases beyond RA if no diagnosis-specific alternative is available.

This Medfyle was published more than two years ago. More recent Medfyle on this topic may now be available.

Expert commentary

Rene Westhovens, MD, PhD

Rheumatologist
Emeritus Professor KU Leuven, Belgium

About this Medfyle
Read more arrow_downward Hide arrow_upward

©2022 Medfyle. All rights reserved.

Original article:

Thiele K, Albrecht K, Zink A, et al. Is the Rheumatoid Arthritis Impact of Disease (RAID) score a meaningful instrument for other inflammatory rheumatic diseases? A cross-sectional analysis of data from the German National Database. RMD Open 2022;8:e002342. doi: 10.1136/rmdopen-2022-002342

The authors of the original article and the publisher were not involved in the creation of the summary.


Feedback